| 2026 | Leveraging tumor multigene panel testing to identify germline variants in gynecologic cancers: A retrospective evaluation of an algorithm-based approach | GYNECOLOGIC ONCOLOGY |
| 2025 | Prognostic implications of HER2 in ovarian cancer: Associations with homologous recombination deficiency and folate receptor alpha expression | GYNECOLOGIC ONCOLOGY |
| 2025 | Genomic Profiling in Patients with Endometrial Cancer by Deep Sequencing of Vaginal Swabs and Plasma | CLINICAL CANCER RESEARCH |
| 2024 | Recent Advances in Genomic Approaches for the Detection of Homologous Recombination Deficiency | CANCER RESEARCH AND TREATMENT |
| 2024 | RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer | FRONTIERS IN ONCOLOGY |
| 2024 | Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer | SCIENTIFIC REPORTS |
| 2024 | Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial | GYNECOLOGIC ONCOLOGY |
| 2024 | Reply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 | INTERNATIONAL JOURNAL OF CANCER |
| 2024 | Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer | CANCER RESEARCH |
| 2023 | Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer | SCIENTIFIC REPORTS |
| 2023 | Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 | INTERNATIONAL JOURNAL OF CANCER |
| 2023 | Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis | JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2023 | Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer | BRITISH JOURNAL OF CANCER |
| 2023 | Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience | Journal of Gynecologic Oncology |
| 2023 | Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian Cancer | CLINICAL CANCER RESEARCH |
| 2023 | RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma | JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2023 | Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer | FRONTIERS IN ONCOLOGY |
| 2023 | Clinical Relevance of Uterine Manipulation on Oncologic Outcome in Robot-Assisted versus Open Surgery in the Management of Endometrial Cancer | JOURNAL OF CLINICAL MEDICINE |
| 2022 | USEFULNESS OF PRE-OPERATIVE PET-CT IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING SENTINEL LYMPH NODE MAPPING: DO NEGATIVE FINDINGS ON PET-CT NEGATIVITY REALLY INDICATE NODE NEGATIVITY? | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTS | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues | Obstetrics & Gynecology Science |
| 2022 | Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? | GYNECOLOGIC ONCOLOGY |
| 2022 | Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer | FRONTIERS IN ONCOLOGY |
| 2022 | Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test | Cancers |
| 2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer | Cancers |
| 2022 | Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study | Gynecologic Oncology |
| 2021 | Comparison between prepubertal and postpubertal patients with obstructed hemivagina and ipsilateral renal anomaly syndrome | Journal of Pediatric Urology |
| 2020 | Predicting labor induction success by cervical funneling in uncomplicated pregnancies
| JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
| 2020 | Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer | JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2018 | Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas.
| Obstetrics & Gynecology Science |
| 2018 | Abnormal lymphatic vessel development is associated with decreased decidual regulatory T cells in severe preeclampsia. | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY |
